MedPath

Tattoo Numbing Cream 18% Lidocaine

Approved
Approval ID

335fe65d-81be-ff45-e063-6294a90a0d0f

Product Type

HUMAN OTC DRUG LABEL

Effective Date

Apr 22, 2025

Manufacturers
FDA

Jiangxi Yudexi Pharmaceutical Co., LTD

DUNS: 455662836

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

LIDOCAINE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code85248-003
Application NumberM017
Product Classification
M
Marketing Category
C200263
G
Generic Name
LIDOCAINE
Product Specifications
Route of AdministrationTOPICAL
Effective DateApril 22, 2025
FDA Product Classification

INGREDIENTS (8)

SOYBEAN LECITHINInactive
Code: 1DI56QDM62
Classification: IACT
LIDOCAINEActive
Quantity: 18 g in 100 g
Code: 98PI200987
Classification: ACTIB
PEPPERMINTActive
Quantity: 10 g in 100 g
Code: V95R5KMY2B
Classification: ACTIB
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT
.ALPHA.-TOCOPHEROL ACETATEInactive
Code: 9E8X80D2L0
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
CARBOMER 934Inactive
Code: Z135WT9208
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Tattoo Numbing Cream 18% Lidocaine - FDA Drug Approval Details